NEW DELHI :
Drug firm Ipca Laboratories Tuesday posted a 52% jump in its net profit at ₹160.18 crore for the third quarter ended December 31, 2018.
The company had posted a net profit of ₹105.58 crore for the same period of previous fiscal.
Total income of the company grew 10% to ₹960.22 crore during the quarter under review as against ₹870.18 crore in the same period of the previous fiscal, Ipca Laboratories said in a regulatory filing.
Shares of the company were trading at ₹736 apiece on BSE, up 0.82% from the previous close.
This story has been published from a wire agency feed without modifications to the text.